<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Inflammatory markers have been associated with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> risk and prognosis after cardiac events </plain></SENT>
<SENT sid="1" pm="."><plain>Their relationship to prognosis after <z:hpo ids='HP_0001297'>stroke</z:hpo> is unsettled </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A population-based study of <z:hpo ids='HP_0001297'>stroke</z:hpo> risk factors in 467 patients with first <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> was undertaken to determine whether levels of high-sensitivity C-reactive protein (hs-CRP) and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>-associated phospholipase A(2) (Lp-PLA2) predict risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> recurrence, other vascular events, and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Levels of Lp-PLA2 and hs-CRP were weakly correlated (r = 0.09; P = .045) </plain></SENT>
<SENT sid="4" pm="."><plain>High-sensitivity CRP, but not Lp-PLA2, was associated with <z:hpo ids='HP_0001297'>stroke</z:hpo> severity </plain></SENT>
<SENT sid="5" pm="."><plain>After adjusting for age, sex, race and ethnicity, history of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, smoking, and hs-CRP level, compared with the lowest quartile of Lp-PLA2, those in the highest quartile had an increased risk of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> (adjusted hazard ratio, 2.08; 95% confidence interval, 1.04-4.18) and of the combined outcome of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo>, MI, or vascular <z:hpo ids='HP_0011420'>death</z:hpo> (adjusted hazard ratio, 1.86; 95% confidence interval, 1.01-3.42) </plain></SENT>
<SENT sid="6" pm="."><plain>After adjusting for confounders, hs-CRP was not associated with risk of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> or recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, or vascular <z:hpo ids='HP_0011420'>death</z:hpo> but was associated with risk of <z:hpo ids='HP_0011420'>death</z:hpo> (adjusted hazard ratio, 2.11; 95% confidence interval, 1.18-3.75) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Inflammatory markers are associated with prognosis after first <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and may offer complementary information </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="1" ids="6495">Lipoprotein</z:chebi>-associated phospholipase A(2) may be a stronger predictor of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> risk </plain></SENT>
<SENT sid="9" pm="."><plain>Levels of hs-CRP, an <z:hpo ids='HP_0011009'>acute</z:hpo>-phase reactant, increase with <z:hpo ids='HP_0001297'>stroke</z:hpo> severity and may be associated with mortality to a greater degree than recurrence </plain></SENT>
</text></document>